Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
20.5M
-
Shares change
-
+185K
-
Total reported value, excl. options
-
$384M
-
Value change
-
+$3.37M
-
Number of buys
-
58
-
Number of sells
-
-43
-
Price
-
$18.75
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q1 2018
121 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q1 2018.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.5M shares
of 50.5M outstanding shares and own 40.56% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.4M shares), VANGUARD GROUP INC (2.33M shares), DIMENSIONAL FUND ADVISORS LP (1.69M shares), FEDERATED INVESTORS INC /PA/ (1.05M shares), Invesco Ltd. (1M shares), STATE STREET CORP (988K shares), TEACHERS ADVISORS, LLC (550K shares), NORTHERN TRUST CORP (467K shares), Bank of New York Mellon Corp (414K shares), and GEODE CAPITAL MANAGEMENT, LLC (341K shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.